New White Paper: Custom manufacturing in pharma – Why only the best survive

16th May 2019

New White Paper: Custom manufacturing in pharma – Why only the best survive

Contract development and manufacturing organisations (CDMOs) in the pharmaceutical world are on the up. They benefit from an increasing number of companies that outsource parts of their production to external service providers. The White Paper ‘Custom manufacturing in pharma – Why only the best survive’ describes the current situation and changes in the pharmaceutical industry and focuses on the key strategies of custom manufacturers to succeed and grow in this fiercely contested market.

The pharmaceutical industry is undergoing a dramatic change. The challenges: empty product pipelines, pressure on prices, and emerging global markets. Custom manufacturers benefit from the challenging conditions and the trend towards outsourcing, but only those who stand out due to particular skills or a wide range of services and the ability to adapt rapidly to changed requirements will survive.

The White Paper gives insights into:

- Key factors driving the market for custom manufacturers
- Opportunities and challenges for the pharmaceuticals industry
- Strategies of successful custom manufacturers
- Outlook

For more information visit www.process-worldwide.com/custom-manufacturing-how-to-survive-in-changing-markets-v-41487-9963/

View more Industry News

Latest News